APLAR rheumatoid arthritis treatment recommendations

Area of Science:

• Rheumatology
• Clinical Guidelines
• Epidemiology

Background:

• Rheumatoid arthritis (RA) affects 1% of the global population, necessitating region-specific treatment guidelines.
• Existing RA guidelines are primarily based on Caucasian populations, potentially limiting their applicability in the Asia-Pacific region.
• The Asia Pacific League of Associations for Rheumatology (APLAR) initiated a project in 2013 to develop tailored RA recommendations.

Framework:

• The AGREE II instrument and ADAPTE Collaboration framework were utilized for systematic guideline adaptation.
• This systematic approach ensured rigorous identification, appraisal, and synthesis of relevant international RA guidelines.
• Adaptation focused on making international evidence applicable to the Asia-Pacific context.

Implementation:

• Forty RA treatment recommendations were drafted based on synthesized evidence and expert consensus.
• These recommendations address the specific needs and challenges of RA management in the Asia-Pacific.
• The development process involved a Steering Committee established by APLAR.

Implications:

• The APLAR RA treatment recommendations provide a benchmark for best practice in the Asia-Pacific.
• These guidelines aim to ensure equitable basic care and enhance patient outcomes for rheumatoid arthritis.
• The document will support national rheumatology associations in developing country-specific guidelines.